Updated:
Tigris Ventures
Tigris Ventures is a seed-stage investment firm and venture incubator focused on healthcare and environment. It has acquired CRISI Medical Systems, ecoATM,...
Tigris Ventures
Tigris Ventures is a seed-stage investment firm and venture incubator focused on healthcare and environment. It has acquired CRISI Medical Systems, ecoATM, Biomatrica, and MD Revolution. The companies work on drug-delivery systems, eco-friendly recycling, biological sample storage, and digital health management.
General information
Firm type
Venture Capital
Year founded
2012
Location
Region
North America
Country
United States
City
San Diego
Corporate office
San Diego, CA, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Tigris Ventures?
No named principals are publicly associated with Tigris Ventures. The firm's website and available public records do not identify a managing partner, investment committee, or any individual officer. For an institutional allocator, this means all governance, key-person risk, and decision-making authority must be established directly with the firm during initial due diligence, as no independent verification is possible from open sources.
What investment stages does Tigris Ventures target?
Tigris Ventures states it invests at the seed and startup stages. The firm does not publicly differentiate between pre-seed, seed, Series A, or follow-on allocations. Without a portfolio log, an allocator cannot observe the firm's typical entry check size, ownership targets, or whether it reserves capital for pro-rata follow-ons in later rounds.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: